- Home
- ANTE vs WINT Comparison
ANTE vs WINT Comparison
Compare ANTE & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- WINT
- Stock Information
- Founded
- ANTE 2005
- WINT 1992
- Country
- ANTE China
- WINT United States
- Employees
- ANTE N/A
- WINT N/A
- Industry
- ANTE Advertising
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ANTE Consumer Discretionary
- WINT Health Care
- Exchange
- ANTE Nasdaq
- WINT Nasdaq
- Market Cap
- ANTE 5.7M
- WINT 5.3M
- IPO Year
- ANTE N/A
- WINT 1995
- Fundamental
- Price
- ANTE $0.49
- WINT $0.50
- Analyst Decision
- ANTE
- WINT Hold
- Analyst Count
- ANTE 0
- WINT 1
- Target Price
- ANTE N/A
- WINT $18.00
- AVG Volume (30 Days)
- ANTE 499.7K
- WINT 549.5K
- Earning Date
- ANTE 12-26-2024
- WINT 11-26-2024
- Dividend Yield
- ANTE N/A
- WINT N/A
- EPS Growth
- ANTE N/A
- WINT N/A
- EPS
- ANTE 2.64
- WINT N/A
- Revenue
- ANTE $500,000.00
- WINT N/A
- Revenue This Year
- ANTE N/A
- WINT N/A
- Revenue Next Year
- ANTE N/A
- WINT N/A
- P/E Ratio
- ANTE $0.17
- WINT N/A
- Revenue Growth
- ANTE N/A
- WINT N/A
- 52 Week Low
- ANTE $0.26
- WINT $0.45
- 52 Week High
- ANTE $2.90
- WINT $22.32
- Technical
- Relative Strength Index (RSI)
- ANTE 48.09
- WINT 27.72
- Support Level
- ANTE $0.45
- WINT $0.45
- Resistance Level
- ANTE $0.58
- WINT $0.64
- Average True Range (ATR)
- ANTE 0.10
- WINT 0.06
- MACD
- ANTE -0.02
- WINT 0.07
- Stochastic Oscillator
- ANTE 11.61
- WINT 19.50
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.